Publications

Complete List of Publications (* as corresponding author)

59.- Multifunctional Nanoassemblies for Cytotoxic Drug and Therapeutic Enzymes Delivery in Neuroblastoma Therapy” Parra‐Nieto, J.; García del Cid, MA.; Galeano, C.; Aguirre de Carcer, I.; García‐García, L.; Gonzalez‐Murillo, A.; Megias, D.; Ramirez, M.; Baeza, A.*.Adv. Mater. Interfaces 2023, 10, 2201356

58.- Nanomaterials and Nanostructures Hand-In-Hand with Biology” Villaverde, G.; Baeza, A.; Gómez-Graña, S. Nanomaterials, 2022,12(14), 2317.

57.- Strategies for the Biofunctionalization of Straining Flow Spinning Regenerated Bombyx mori Fibers” Lozano-Picazo, P.; Castro-Domínguez, C.; Bruno, AL.; Baeza, A.; Martínez, AS.; López, PA.; Castro, A.; Lakhal, Y.; Montero, E.; Colchero, L.; González-Nieto, D.; Rojo, FJ.; Panetsos, F.; Ramos, M.; Daza, R.; Gañán-Calvo, AM.; Elices, M.; Guinea, GV.; Pérez-Rigueiro, J. Pharmaceutics, 2022, 14 (4), 784.

56.- Bacteria as Nanoparticle Carriers for Immunotherapy in Oncology” Moreno, V. M.; Baeza, A.* Pharmaceutics, 2022, 14 (4), 784.

55.- Nano‐and Microscale Drug Delivery Approaches for Therapeutic Immunomodulation” Paris, J. L.; Baeza, A.* ChemNanoMat, 2021, 7 (7), 773-788.

54.- UVA-Degradable Collagenase Nanocapsules as a Potential Treatment for Fibrotic Diseases” Moreno, V.M.; Meroño, C.; Baeza, A.*; Usategui, A.; Ortiz-Romero, P. L.; Pablos, J. L.; Vallet-Regí, M. Pharmaceutics, 2021, 13, 499.

53.- Evaluation of the Penetration Process of Fluorescent Collagenase Nanocapsules in a 3D Collagen Gel” Moreno, V.M.; Baeza, A.*; Vallet-Regí, M. Acta Biomaterialia, 2021, 121, 263-274.

52.- Inorganic porous nanoparticles for drug delivery in antitumoral therapy” Parra, J; García del Cid, M. A.; Aguirre de carcer, I.; Baeza, A.* Biotechnology Journal, 2021, 16, 2000150. doi.org/10.1002/biot.202000150.

51.- Bacteria as nanoparticles carrier for enhancing penetration in a tumoral matrix model” Moreno, V. M.; Álvarez, E.; Izquierdo-Barba, I.; Baeza, A.*; Serrano-López, J.; Vallet-Regí, M. Adv. Matter. Interfaces, 2020, 7, 1901942. doi: 10.1002/admi.201901942 (Selected as Cover)

50.- Tumor targeted nanocarriers for immunotherapyBaeza, A.* Molecules 202025, 1508. (Selected as Front Cover)

49.- “Mesoporous silica nanoparticles as theranostic antitumoral nanomedicines” Baeza, A.*; Vallet-Regí, M. Pharmaceutics, 2020, 12(10), 957.

48.- ” Overcoming the stability, toxicity, and biodegradation challenges of tumor stimuli-responsive inorganic nanoparticles for delivery of cancer therapeutics” Paris, J. L; Baeza, A.; Vallet-Regí, M. Expert Opin. Drug Deliv., 2019, 16, 1095-1112.

47.- “Molecular Scaffolds as Double‐Targeting Agents For the Diagnosis and Treatment of Neuroblastoma” Villaverde, G.; Alfranca, A.; Gonzalez-Murillo, A.; Melen, G. J.; Castillo, R. R.; Ramírez,M.; Baeza, A.*; Vallet-Regí, M. Angew. Chem. Int. Ed. 2019, 58, 3067–3072.

46.- “Targeting strategies for improving the efficacy of nanomedicine in oncology” Villaverde, G.; Baeza, A.* Beilstein J. Nanotechnol. 2019, 10, 168–181.

45.- “Multifunctional Protocells for Enhanced Penetration in 3D Extracellular Tumoral Matrices” Villegas, M. R.; Baeza, A.*; Noureddine, A.; Durfee, P. N.; Butler, K. S.; Agola, J. O.; Brinker, C. J.; Vallet-Regí, M. Chem. Matter., 2018, 30, 112-120.

44.- “Collagenase nanocapsules: An approach to fibrosis treatment” Villegas, M. R.; Baeza, A.*; Usategui, A.; Ortiz-Romero, P. L.; Pablos, J. L.; Vallet-Regí, M. Acta Biomaterialia, 2018, 74, 430-438.

43.- “Nanomotors for nucleic acid, proteins, pollutants and cells detection” Baeza, A.*; Vallet-Regí, M. Int. J. Mol. Sci. 2018, 19, 1579.

42.- “Targeted Chemo-Photo Thermal Therapy: a Nanomedicine Approximation to Selective Melanoma Treatment” Villaverde, G.; Gómez-Graña, S.; Guisasola, E.; García, I.; Hanske, C.; Liz-Marzán, L. M.; Baeza, A.*; Vallet-Regí, M. Part. Part. Syst. Char., 2018, 35, 1800148.

41.- “Nanotechnological Strategies for Protein Delivery” Villegas, M. R.; Baeza, A.*; Vallet-Regí, M. Molecules, 2018, 23, 1008.

40.- “Heating at the Nanoscale through Drug-Delivery Devices: Fabrication and Synergic Effects in Cancer Treatment with Nanoparticles” Guisasola, E.; Baeza, A.; Asín, L.; de la Fuente, J. M.; Vallet-Regí, M. Small Methods, 2018, 2, 1800007.

39.- “Beyond Traditional Hyperthermia: In Vivo Cancer Treatment with Magnetic-Responsive Mesoporous Silica Nanocarriers” Guisasola, E.; Asin, L.; Beola, L.; de la Fuente, J. M.; Baeza, A.*, Vallet-Regí, M. ACS Appl. Mater. Interfaces, 2018, 10, 12518–12525.

38.- “Polydopamine-like Coatings as Payload Gatekeepers for Mesoporous Silica Nanoparticles” Moreno-Villaécija, M. A.; Sedó-Vegara, J.; Guisasola, E.; Baeza, A.; Vallet Regí, M.; Nador, F.; Ruiz-Molina, D. ACS Appl. Mater. Interfaces, 2018, 10, 7661–7669.

37.- “Proteolytic Enzymes and Cavitation as Strategies to Enhanced Penetration of Drug Nanocarriers” Villegas, M. R.; Baeza, A.; Vallet-Regí. Material Sci & Eng Int J 2018, 2(1): 00028.

36.- “A novel visible light responsive nanosystem for cancer treatment” Martínez-Carmona, M.; Lozano, D.; Baeza, A.; Vallet-Regí, M. Nanoscale, 2017, 9, 15967-15973.

35.- “Janus mesoporous silica nanoparticles for dual-targeting for tumoral cells and mitochondria” López, V.; Villegas, M. R.; Rodríguez, V.; Villaverde, G.; Lozano, D.; Baeza, A.*; Vallet-Regí, M. ACS Appl. Mater. Interfaces, 2017, 9, 26697–26706.

34.- “Double Sequential Encrypted Targeting Sequence: A New Concept for Bone Cancer Treatment” Villaverde, G.; Nairi, V.; Baeza, A.*; Vallet-Regí, M. Chem. Eur. J. 2017, 23, 7174-7179. (Selected as hot paper and Frontspice Cover)

33.- “Electron microscopy for inorganic-type drug delivery nanocarriers for antitumoral applications: what does it reveal?” Baeza, A.; Castillo, R. R.; Torres-Pardo, A.; González-Calbet, J. M.; Vallet-Regí, M. J. Mat. Chem. B, 2017, 15, 2714-2725.2

31.- “Synthesis of Polydopamine-Like Nanocapsules via removal of a Sacrificial Mesoporous Silica Template with Water” Nador, F.; Guisasola, E.; Baeza, A.; Moreno-Villaecija, M. A.; Vallet-Regí, M.; Ruiz-Molina, D. Chem. Eur. J., 2017, 23, 2753-2758 (selected as Journal Cover).

30.- “Dynamics of Novel Photoactive AgCl Microstars and Their Environmental Applications” Simmchen, J.; Baeza, A.; Niguel-López, A.; Stanton, M. M.; Vallet-Regí, M.; Ruiz-Molina, D.; Sánchez, S. ChemNanoMat, 2017, 3, 65-71. (selected as Back Journal Cover).

29.- “Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks” Baeza, A.*; Ruiz-Molina, D.; Vallet-Regí, M. Expert Opin. Drug Deliv. 2017, 14, 783-796.

28.- “Targeted Mesoporous Silica Nanocarriers in Oncology” Baeza, A.; Vallet-Regí, M. Curr. Drug Targets, 2016, Vol 17(doi: 10.2174/1389450117666160603023037).

27.- “Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution” Baeza, A.; Colilla, M.; Manzano, M.; Vallet-Regí, M. Biomater. Sci., 2016, 4, 803-813.

26.- “Design of thermoresponsive polymeric gates with opposite drug delivery behaviors” Guisasola, E.; Baeza, A.; Talelli, M.; Arcos. D.; Vallet-Regí, M. RSC Advances, 2016, 6, 42510-42516.

25.- “Magnetic-Responsive Release Controlled by Hot Spot Effect” Guisasola, E.; Baeza, A.; Talelli, M.; Arcos, D.; Moros, M.; de la Fuente, J.; Vallet-Regí, M. Langmuir, 2015, 31, 12777–12782.

24.- “Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues” Villegas, M.; Baeza, A.*; Vallet-Regí, M. ACS Appl. Mater. Interfaces, 2015, 7, 24075–24081.

23.- “Mesoporous Silica Nanoparticles Functionalized with Carbosilane Dendrons: Nonviral Vectors for in vitro ssDNA Oligonucleotides Delivery” Martínez, A.; Fuentes-Paniagua, E.; Baeza, A.; Sánchez-Nieves, J.; Cicuendez, M.; Gómez, R.; Javier de la Mata, F.; González, B.; Vallet-Regí, M. Chem. Eur. J. 2015, 21(44), 15651–15666. (Selected as hot paper).

22.- “Mesoporous silica nanoparticles grafted with light-responsive protein shell for highly cytotoxic antitumoral therapy” Martínez-Carmona, M.; Baeza, A.*, Rodriguez-Milla, M. A.; García-Castro, J.; Vallet-Regí, M. J. Mat. Chem. B, 2015, 3, 5746-5752.

21.- “Novel targeting agents for selective nanocarriers against neuroblastoma” Villaverde, G.; Baeza, A.*; Melen, G. J.; Ramírez, M.; Vallet-Regí, M. J. Mat. Chem. B, 2015, 3, 4831-4842.

20.- “Smart Mesoporous Silica Nanocarriers for antitumoral therapy” Baeza, A.; Vallet-Regí, M. Current Topics Med. Chem., 2015, 15(22), 2306-2315.

19.- “Advances in Mesoporous Silica Nanoparticles for Targeted Stimuli-Responsive Drug Delivery” Baeza, A.; Colilla, M.; Vallet-Regí, M. Expert Opin. Drug Deliv., 2015, 12(2), 319-337.

18.- “Hybrid enzyme-polymeric capsules/mesoporous silica nanodevice for in situ cytotoxic agent generation” Baeza, A.*; Guisasola, E. Torres-Pardo, A.; González-Calbet, J. M.; Melen, G. J.; Ramirez, M.; Vallet-Regí, M. Adv. Func. Matter., 2014, 24, 4625–4633.

17.- Improving biocatalytic self-propelled motion by enzyme encapsulation” Simmchen, J.; Baeza, A.*; Ruiz-Molina, D.; Vallet-Regí, M. Nanoscale, 2014, 6,  8907-8913.

16.- Effect of surfactants on the performance of tubular and spherical micromotors – a comparative study of mechanisms” Simmchen, J.; Magdanzc, V.; Sanchez, S.; Chokmaviroj, S.; Ruiz-Molina, D.; Baeza, A.; Schmidt, O. G. RSC Advances, 2014, 4, 20334-20340.

15.- “Towards the development of 3D “gated scaffolds” for on-command delivery using capped mesoporous silica nanoparticles” Mas, N.; Arcos, D.; Aznar, E.; Sánchez-Salcedo, S.; Sancenón, F.; García, A.; Marcos, M. D.; Baeza, A.; Vallet-Regí, M.; Martínez-Máñez, R. Small, 2014, 10, 4859-4864.

14.- “Thermoseeds for interstitial magnetic hyperthermia: from bioceramics to nanoparticles” Baeza, A.; Arcos, D.; Vallet-Regí, M. J. Phys.: Condens. Matter, 2013, 25, 484003.

13.- “In-vivo behavior of Si-hydroxyapatite/polycaprolactone/DMB scaffolds fabricated by 3D printing” Meseguer-Olmo, L.; Vicente-Ortega, V.; Alcaraz-Baños, M.; Calvo-Guirado, J. L.; Vallet-Regí, M.; Arcos, D.; Baeza, A. J. Biomed. Mater. Res. A. 2013, 101A, 2038-2048.

12.- “Asymmetric hybrid silica nanomotors for capture and cargo transport: Towards a novel motion-based DNA sensor” Simmchem, J.; Baeza, A.*; Ruiz-Molina, D.; Esplandiu-Egido, M. J.; Vallet-Regí, M. Small, 2012, 8, 2053-2059.

11.- “Magnetically triggered multi-drug release by hybrid mesoporous nanoparticles” Baeza, A.; Guisasola, E.; Ruiz-Hernández, E.; Vallet-Regí, M. Chem. Mater., 2012, 24, 517-524.

10.- “Design of smart materials for drug and gene delivery”. Vallet-Regí, M.; Ruiz-Hernández, E.; Gónzalez, B.; Baeza, A. Journal of Biomaterials and Tissue Eng. 2011, 1, 6-29.

9.- “Smart Drug Delivery through DNA/ Magnetic Nanoparticle Gates “. Ruiz-Hernandez, E.; Baeza, A.; Vallet-Regí, M. ACS Nano, 2011, 5 (2), 1259-1266. (selected as top teen most read articles of Q1 2011).

8.- “Biotinylation of silicon-doped hydroxyapatite: A new approach to protein fixation for bone tissue regeneration”. Baeza, A.; Izquierdo-Barba, I.; Vallet-Regí, M. Acta Biomaterialia, 2010, 6 (3), 743-749.

7.- “Aldehyde Selective Wacker Oxidations of phthalimid protected allylic amines: a new catalytic route to amino acids”. Weiner, B.; Baeza, A.; Jephargon, T.; Feringa, B. L. J. Am. Chem. Soc., 2009, 131 (27), 9473–9474.

6.- “Application of Selective Palladium-Mediated Functionalization of the Pyrido[3′,2′:4,5]pyrrolo[1,2-c]pyrimidine Heterocyclic System for the Total Synthesis of Variolin B and Deoxyvariolin B”. Baeza, A.; Mendiola, J.; Burgos, C.; Álvarez-Builla, J.; Vaquero, J. J. Eur. J. Org. Chem., 2010, 29, 5607-5618.

5.- “Palladium-mediated C-N, C-C and C-O funcionalization of azolopyrimidines: A new total synthesis of variolin B”. Baeza, A.; Mendiola, J.; Burgos, C.; Álvarez-Builla, J.; Vaquero, J. J. Tetrahedron Lett.,2008, 49, 4073-4077.

4.- “Novel environmentally benign procedures for the synthesis of styryl dyes” Vasilev, A.; Deligeorgiev, T.; Gadjev, N.; Kalayanova, S.; Vaquero, J. J.; Álvarez-Builla, J.; Baeza, A. Dyes and pigments, 2008, 77, 550-555. (Selected as Green Innovation of the Month (May-2008) by Chemical week sustainability).

3.- “Selective palladium-catalyzed amination of the heterocyclic core of variolins”. Baeza, A.; Burgos, C.; Álvarez-Builla, J.; Vaquero, J.J. Tetrahedron Lett. 2007, 48, 2597-2601.

2.- “Heterocyclizations with Tosylmethylisocyanide derivatives. A new approach to substituted azolopyrimidines”. Baeza, A.; Mendiola, J.; Burgos, C.; Álvarez-Builla, J. and Vaquero, J. J. J. Org. Chem., 2005, 70, 4879-4882.

1.- “Reaction of Bromomethylazoles and Tosylmethylisocyanide (TosMIC). A novel heterocyclization method for the synthesis of the core of Marine alkaloids Variolins and related azolopyrimidines”. Mendiola, J.; Baeza, A.; Álvarez-Builla, J.; Vaquero, J. J.* J. Org. Chem., 2004, 69, 4974-4983.